Genetically delivered antibody protects against West Nile virus
- 31 January 2008
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 77 (1) , 6-13
- https://doi.org/10.1016/j.antiviral.2007.08.010
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory TractJournal of Molecular Biology, 2007
- Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope ProteinJournal of Virology, 2006
- Crystal Structure of the West Nile Virus Envelope GlycoproteinJournal of Virology, 2006
- Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile VirusJournal of Virology, 2006
- Neutralizing Monoclonal Antibodies Against Russian Strain of the West Nile VirusViral Immunology, 2005
- Antibody Prophylaxis and Therapy against West NileVirus Infection in Wild-Type and ImmunodeficientMiceJournal of Virology, 2003
- A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancerCancer Gene Therapy, 2002
- Assessment of Adenoviral Vector Safety and Toxicity: Report of the National Institutes of Health Recombinant DNA Advisory CommitteeHuman Gene Therapy, 2002
- A family of vectors for surface display and production of antibodiesGene, 1993
- Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virusArchiv für die gesamte Virusforschung, 1987